Press release
Antineoplastic Agents Market 2016-2024: by Product Type, End User, by Geography and Company Profile
Antineoplastic Agents Market
Read Report @ https://www.persistencemarketresearch.com/market-research/antineoplastic-agents-market.asp
Factors such as growing incidence of cancer across the globe and demand for cost-effective treatment options are believed to play crucial role for the growth of global anti-neoplastic agents market. Rapid innovation in the field of personalized medicine presents a huge opportunity to manufacturers of anti-neoplastic agents. However, heterogeneous nature of cancer and high development cost of neoplastic agents are the factors limiting the growth of global anti-neoplastic agents market.
Increasing investment by multinational companies in cancer research owing to increasing prevalence of cancer is expected to boost the global market for anti-neoplastic agents during the forecast period. Based on product type, anti-neoplastic agents are classified as chemotherapeutic agents, biological or immunotherapeutic agents and personalized medicine. Chemotherapeutic agents segment is foreseen to lead the market owing to easy availability of drugs and immunotherapeutic agents segment is expected grow rapidly due to increasing acceptance of biological therapy owing to lesser side effects.
On the basis of end user, the global chemotherapeutic agents market has been segmented into hospitals, Clinics, cancer rehabilitation center and ambulatory surgical centers. Hospital end user segment is anticipated to contribute the maximum share among end users. As per the statistics given by The Healthcare Cost and Utilization Project (H-CUP), there were 4.7 Mn hospitalizations related to cancer in U.S. in year 2009 and about 6% of adult inpatient hospital cost was generated by hospitalization of cancer patients.
Request Sample Report @ https://www.persistencemarketresearch.com/samples/10741
On the basis of regional presence, anti-neoplastic agents market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America will continue to dominate the global anti-neoplastic agents market for due to high prevalence of malignant neoplasm. Europe is expected to hold second largest market share in global anti-neoplastic agents market. In 2013, as per Cancer Research UK, 605 people per 100,000 general population were diagnosed with cancer.
Some of the major players in global anti-neoplastic agents market include Hoffmann-La Roche Ltd., Amgen Inc., Bristol-Myers Squibb Company, Baxter Healthcare Corporation, Boehringer Ingelheim GmbH, Aspen Global Inc., Bayer AG, Teva pharmaceutical Industries Ltd., Johnson & Johnson Pvt. Ltd., Merc & Co., Inc., Pfize Inc., Accord Healthcare, Inc., Genentech, Inc., Lundbeck LLC, AbbVie Inc. and others.
Buy now @ https://www.persistencemarketresearch.com/checkout/10741
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antineoplastic Agents Market 2016-2024: by Product Type, End User, by Geography and Company Profile here
News-ID: 842504 • Views: …
More Releases from Persistance Market Research
DNA/RNA Extraction Machine Market to Grow at 7.2% CAGR Through 2031, Says Persis …
The global DNA/RNA extraction machine market is poised for significant expansion, fueled by the rise of molecular diagnostics, the genomics boom, and increasing investments in biomedical research. These machines serve a critical role in isolating and purifying nucleic acids from various biological samples, forming the foundation for downstream applications like PCR, sequencing, and diagnostics.
In 2024, the DNA/RNA extraction machine market is estimated at US$1.4 billion, with forecasts projecting growth…
Quinoa Market Set to Hit US$2.3 Bn by 2031, Riding a Strong 9.8% CAGR
The global quinoa market is poised for remarkable growth in the coming years, with projections estimating a market value of US$2.3 billion by 2031, up from US$1.2 billion in 2024. Driven by increasing consumer demand for nutritious and organic food options, the market is expected to register a CAGR of 9.8% between 2024 and 2031, According to Persistence Market Research.
Request a sample report@ https://www.persistencemarketresearch.com/samples/34798
Key Market Drivers
One of the key drivers…
Evolving Trends in the Insulin Pens Market: A Comprehensive Report
Market Overview:
The Insulin Pens Market has witnessed remarkable growth and innovation over the years. Insulin pens are medical devices used by individuals with diabetes to administer insulin easily and accurately. These devices have become an integral part of diabetes management, offering numerous advantages over traditional insulin delivery methods, such as syringes and vials.
In 2022, the global market for insulin pens brought in US$ 16.2 billion in revenue and is predicted…
Smart Machines Market to register growth at a CAGR of 20.1% throughout 2023-2033
The market for smart machines was valued at US$ 73,456.2 Mn in 2022, and it is expected to grow to US$ 5,44,986.6 Mn by the end of 2033. In 2023, the market for smart machines is expected to be worth US$ 87,045.6 Mn. From 2023 to 2033, the market for Smart Machines is expected to grow at a CAGR of 20.1%.
The market for artificially intelligent machines and systems that can…
More Releases for Antineoplastic
Antineoplastic Agents Market is Estimated to Reach USD 286.49 Billion by 2033 | …
The global antineoplastic agents market is valued at USD 126.71 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.5%, reaching USD 286.49 billion by 2033. This substantial expansion is driven by the rising prevalence of cancer, increasing investments in research and development (R&D), and the growing aging population susceptible to chronic diseases.
For More Insights into the Market, Request a Sample of…
Prominent Anti-Neoplastic Agents Market Trend for 2025: Leading Companies Drive …
How Are the key drivers contributing to the expansion of the anti-neoplastic agents market?
The growth of the antineoplastic agent market is predicted to be spurred by an increasing number of cancer cases. Antineoplastic agents are crucial in cancer management, as they inhibit the proliferation and division of cancerous cells. This occurs through a variety of mechanisms that inflict DNA damage, disrupt the cell cycle, and interrupt vital cellular processes. For…
Antineoplastic Agents Market Is Expected to Reach a Valuation of US$ 286.49 Bill …
The market for antineoplastic agents is expected to reach a value of US$ 126.71 billion in 2023 and grow at an estimated CAGR of 8.5% between 2023 and 2033. Cancer is treated with pharmaceuticals known as antineoplastic agents or drugs. Antineoplastic drugs sometimes go by the labels chemotherapy, cytotoxic, and anticancer. These drugs are available as liquids or pills. People are more aware of cancer and its therapies as it…
Antineoplastic Drugs Market 2022 Disclosing Latest Trends And Advancement Outloo …
Antineoplastic Drugs Market Report 2022 is an objective and in-depth study of the current state aimed at the major drivers, market strategies, and key players growth. The Antineoplastic Drugs study also involves the important Achievements of the market, Research & Development, new product launch, product responses and regional growth of the leading competitors operating in the market on a universal and local scale. The structured analysis contains graphical as well…
Antineoplastic Interferon Drug Market By Equipment, Application, By Region, Anal …
The Antineoplastic Interferon Drug Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.
Antineoplastic interferon drug are the agents promising therapeutic approaches for the treatment of…
Antineoplastic Interferon Drug Market Size and Drivers is Responsible to for Inc …
The Antineoplastic Interferon Drug Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.
Antineoplastic interferon drug are the agents promising therapeutic approaches for the treatment of…
